InChI=1S/C20H32O3/c1-2-3-12-15-18-19(23-18)16-13-10-8-6-4-5-7-9-11-14-17-20(21)22/h4,6-7,9-10,13,18-19H,2-3,5,8,11-12,14-17H2,1H3,(H,21,22)/b6-4-,9-7-,13-10-/t18-,19+/m1/s1 |
JBSCUHKPLGKXKH-KZTFMOQPSA-N |
C(CCC)C[C@@H]1[C@H](C/C=C\C/C=C\C/C=C\CCCC(O)=O)O1 |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via 14,15-EET )
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via EET )
|
|
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
(via EET )
anti-inflammatory drug
A substance that reduces or suppresses inflammation.
(via EET )
|
|
View more via ChEBI Ontology
Outgoing
|
(14S,15R)-EET
(CHEBI:132274)
is a
14,15-EET
(CHEBI:34157)
(14S,15R)-EET
(CHEBI:132274)
is conjugate acid of
(14S,15R)-EET(1−)
(CHEBI:131964)
(14S,15R)-EET
(CHEBI:132274)
is enantiomer of
(14R,15S)-EET
(CHEBI:132275)
|
|
Incoming
|
(14S,15R)-EET(1−)
(CHEBI:131964)
is conjugate base of
(14S,15R)-EET
(CHEBI:132274)
(14R,15S)-EET
(CHEBI:132275)
is enantiomer of
(14S,15R)-EET
(CHEBI:132274)
|
(5Z,8Z,11Z)-13-[(2S,3R)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoic acid
|
(14S,15R)-EpETrE
|
ChEBI
|
(14S,15R)-epoxy-(5Z,8Z,11Z)-eicosatrienoic acid
|
ChEBI
|
(14S,15R)-epoxy-(5Z,8Z,11Z)-icosatrienoic acid
|
ChEBI
|
14S,15R-EET
|
LIPID MAPS
|
14S,15R-EpETrE
|
LIPID MAPS
|
14S,15R-epoxy-5Z,8Z,11Z-eicosatrienoic acid
|
LIPID MAPS
|
4703442
|
Reaxys Registry Number
|
Reaxys
|
12840027
|
PubMed citation
|
Europe PMC
|
9822682
|
PubMed citation
|
Europe PMC
|
|